Microfluidic systems for drug discovery, pharmaceutical analysis, and diagnostic applications

Author(s):  
Dawei Ding ◽  
Sol Park ◽  
Jaspreet Singh Kochhar ◽  
Sui Yung Chan ◽  
Pei Shi Ong ◽  
...  
2006 ◽  
Vol 11 (7) ◽  
pp. 773-781 ◽  
Author(s):  
Peter Porschewski ◽  
Mira A.-M. Grättinger ◽  
Kerstin Klenzke ◽  
Anja Erpenbach ◽  
Michael R. Blind ◽  
...  

Most applications of xMAP™ (Luminex®) bead-based assay technology in diagnostics and drug discovery use immobilized antigens or antibodies. Here the authors describe the development of novel assay systems in which synthetic oligonucleotides that specifically bind and inhibit other biomolecules—so-called aptamers—are directly immobilized on beads. The robustness, specificity, and sensitivity of aptamer-based assays were demonstrated in a test system that detected human α-thrombin in serum samples. xMAP technology was also adapted to competitive screening formats where an aptamer/protein complex was disrupted by a functionally analogous competitor. The results indicate that such assays are excellently suited for diagnostic applications or drug screening, where aptamers serve as competitive binding probes for the identification of small-molecule hits. These methods should be transferable to a large number of applications because specific aptamers can be rapidly generated for almost any protein target.


2020 ◽  
Vol 179 ◽  
pp. 112982
Author(s):  
Saurabh B. Ganorkar ◽  
Yvan Vander Heyden ◽  
Atul A. Shirkhedkar ◽  
Deepak K. Lokwani ◽  
Dinesh M. Dhumal ◽  
...  

2003 ◽  
Vol 8 (19) ◽  
pp. 889-897 ◽  
Author(s):  
Hwee-Ling Koh ◽  
Wai-Ping Yau ◽  
Pei-Shi Ong ◽  
Akhil Hegde

Author(s):  
J.A. Maksem ◽  
C. VanDyke ◽  
H.W. Carter ◽  
C.F. Galang

In the last decade fine needle aspiraration biopsy has gained recognition as a valuable diagnostic technique, and its benefits have been demonstrated in large series of patients with almost every type of tumor (1,2). The usual way to collect cellular material from needle-aspiration biopsies is to discharge the needle and syringe contents onto a microscopic slide and smear the material with another slide. The entire specimen is contained on the slides prepared at the time of biopsy. Serious technical difficulties are inherent to this method. 1) Inconsistent fixation, 2) drying artifact, 3) loss of tissue fragments, 4) inability to confirm impressions by a “second method”, and 5) retention of significant diagnostic material in the needle hub. Our technique avoids these difficulties.


Sign in / Sign up

Export Citation Format

Share Document